Oakley Capital Invests in ProductLife Group
May 28, 2024
Oakley Capital Fund V is investing in ProductLife Group, a European provider of outsourced development, regulatory and compliance services to the life sciences industry. Oakley will partner with management and reinvesting shareholder 21 Invest to support international expansion, accelerate AI-driven technology enablement, and pursue a buy-and-build strategy.
- Buyers
- Oakley Capital (Oakley Capital Fund V)
- Targets
- ProductLife Group
- Sellers
- 21 Invest
- Industry
- Pharmaceuticals
- Location
- Île-de-France, France
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.